In the BioHarmony Drug Report Database
Fostemsavir tromethamine
Rukobia (fostemsavir tromethamine) is a small molecule pharmaceutical. Fostemsavir tromethamine was first approved as Rukobia on 2020-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Rukobia’s patent is valid until 2027-11-19 (FDA).
Trade Name
|
Rukobia |
|---|---|
Common Name
|
fostemsavir tromethamine |
ChEMBL ID
|
CHEMBL3301598 |
Indication
|
hiv infections |
Drug Class
|
Antivirals; phosphoro-derivatives |
Image (chem structure or protein)